Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Arden Farms first to test deer for Johne’s Disease using Actiphage

Arden Farms are the first to use the Actiphage blood test to test their herd of Red Deer for Johne’s Disease. This wasting condition is difficult to detect as it can lay dormant in the animal for many years until it is triggered by stress.

Loading...
Colerado cows

Colorado Laboratory trials new Actiphage test to improve bovine TB diagnosis

The Animal Health Laboratory within the Colorado Department of Agriculture is assisting in a trial of Actiphage®, a new rapid...

Arden Farms, near Market Rasen in Lincolnshire, has 450 hinds and followers. The deer are fed on grass or home-grown silage and the venison is very tender and nutritious.

Farmer Sarah Arden explains that Johne’s Disease is difficult to diagnose. “Deer can be infected with Johne’s Disease for many years without showing any symptoms, so it can be in the herd, but you don’t know about it.

“It is thought that by the time the animal is showing symptoms it is already shedding the bacteria in its faeces which then creates an infection risk for other animals.

“There is an Elisa test that can be used to diagnose Johne’s Disease in deer, that detects antibody responses. The sensitivity of these tests in the early stages of infection are not good, so it often only gives a positive result once the deer is showing clinical signs of the disease.”

Arden Farms were invited to take part in research being carried by the University of Nottingham on behalf of PBD Biotech, developers of the Actiphage blood test.

The study, published in the Frontiers in Veterinary Science, showed that Actiphage reliably identified Johne’s Disease at an early stage of infection. These insights can enable the farmer to isolate the infected animals and restrict the progression of the disease through the herd.

Sarah says: “Actiphage is a useful tool for detecting carriers of the disease. It can identify live bacteria in the blood at very low levels.

“The research showed that a small group of older hinds were carrying the mycobacteria that causes Johne’s Disease. We thought this was such a useful thing to know that we tested the whole herd and removed the carriers to eradicate the disease from the herd.

“We now use Actiphage to test deer before we introduce them to the herd, so we can maintain a disease-free status.

“We chose the deer for their conformation, temperament and now we can select those without Johne’s. The vet can easily fit the blood test along with other procedures to check the health of the animals.”

Actiphage is now being used routinely by Arden Farms to keep it free of Johne’s Disease.

Read more about the development of a rapid method for detection of Johne’s disease in blood samples from farmed deer on the Research page.

Related content

Loading...
Red deer

First Venison Group reviews new Actiphage blood test for deer herds

October 28, 2019
To support its members in keeping their deer herds disease free, the First Venison Group invited Dr Cath Rees, co-founder of PBD Biotech, to talk about the new test for MAP and other mycobacteria at its AGM.
Red deer

First Venison Group reviews new Actiphage blood test for deer herds

October 28, 2019
To support its members in keeping their deer herds disease free, the First Venison Group invited Dr Cath Rees, co-founder...
Deer

18 September 2019

First Venison talk on new TB test for deer

August 13, 2019
Dr Cath Rees, chief scientific offer at PBD Biotech, has been invited to talk to the First Venison group at their annual AGM.
Deer

18 September 2019

First Venison talk on new TB test for deer

August 13, 2019
Dr Cath Rees, chief scientific offer at PBD Biotech, has been invited to talk to the First Venison group at...
Giraffe

New test delivers early identification of TB in exotic animals

November 8, 2018
Bovine tuberculosis, caused by Mycobacterium bovis, is a growing problem for zoos and wildlife parks, especially with the disease’s potential to spread from one species to another, creating a natural reservoir that is difficult to control.
Giraffe

New test delivers early identification of TB in exotic animals

November 8, 2018
Bovine tuberculosis, caused by Mycobacterium bovis, is a growing problem for zoos and wildlife parks, especially with the disease’s potential...

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More